Navigation Links
Celtic Therapeutics and Resolvyx Pharmaceuticals Announce an Alliance in Ophthalmology
Date:10/26/2010

has already demonstrated impressive efficacy and safety in patients with dry eye syndrome," commented Peter B. Corr, Co-Founder and Managing General Partner of Celtic Therapeutics. "The market for dry eye products has grown substantially over the past several years, despite the fact that most patients are not satisfied with current therapeutic options. With the potential for improved efficacy, a much faster onset of action, an improved tolerability profile, and a strong patent estate, we believe RX-10045, if approved, would represent an important step forward in the treatment of this widely prevalent condition."

"We are delighted to be allied with Celtic Therapeutics in maximizing the therapeutic potential of Resolvins to treat dry eye syndrome and other eye disease," said Jamie Nichols, Chief Operating Officer at Resolvyx. "Celtic Therapeutics brings both the capital and the world class development expertise to advance RX-10045 through Phase III development in dry eye and to maximize the potential of Resolvins to treat eye disease more broadly. This will allow Resolvyx to dedicate our resources to pursue the exceptional therapeutic potential of resolvins for non-ophthalmic diseases."

"Our investment in Resolvyx and RX-10045 demonstrates Celtic Therapeutics' focus on novel classes of biologic or small molecule therapeutics that hold the promise of significant medical advances compared to currently available treatment options," commented Stephen Evans-Freke, Co-Founder and Managing General Partner of Celtic Therapeutics. "This is the fourth such transaction we have announced to date; we have previously announced our investment in Kolltan Pharmaceuticals, which is developing second-generation monoclonal antibody drugs targeting tyrosine kinase receptors for the treatment of many cancer types, and alliances with Spirogen for the development of small molecule cytotoxic anti-cancer drugs designed to circumvent drug-resistance mechanisms, and with Bellus H
'/>"/>

SOURCE Celtic Pharmaceutical Holdings L.P.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Celtic Pharma Announces Issuance of U.S. Patent 7,816,323 for Xerecept® in Combination with Avastin® as a Treatment for Breast and Colon Cancers
2. Celtic Pharma Announces Initiation of Phase III Trial of TDT 067 for the Treatment of Onychomycosis
3. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
4. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
5. Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009
6. Celtic Pharma Provides Update on XERECEPT(R) Clinical Program
7. Protalix BioTherapeutics to Present at Two Upcoming Healthcare Conferences
8. Algeta and Lumiphore Announce Global Agreement for the Development of Targeted Alpha-Pharmaceutical Therapeutics
9. BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors
10. Prime Therapeutics Receives 2011 TIPPS Certification
11. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  On July 31, the Food and Drug Administration ... moving forward to regulate laboratory-developed tests (LDTs). The clock ... the U.S. will need to comply with a host ... may subscribe to the strategy to simply sit back ... place, it,s widely acknowledged that failure to answer key ...
(Date:9/2/2014)... 2014 Reportlinker.com announces that a new market ... Asia - Pacific Minimally Invasive Surgery Spinal Device ... The growth rate of the Asia-Pacific ... at double-digit levels throughout the forecast period. Increasingly, young ... this field. The Asia-Pacific and ...
(Date:9/2/2014)... , Sept. 2, 2014 Reportlinker.com ... available in its catalogue: BRIC ... http://www.reportlinker.com/p02343483/BRIC-Bariatric-Surgery-Devices-Market-Outlook-to-2020.html BRIC ... Summary GlobalData,s new report, ... provides key market data on the BRIC Bariatric ...
Breaking Medicine Technology:FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10BRIC Bariatric Surgery Devices Market Outlook to 2020 2BRIC Bariatric Surgery Devices Market Outlook to 2020 3BRIC Bariatric Surgery Devices Market Outlook to 2020 4BRIC Bariatric Surgery Devices Market Outlook to 2020 5BRIC Bariatric Surgery Devices Market Outlook to 2020 6BRIC Bariatric Surgery Devices Market Outlook to 2020 7BRIC Bariatric Surgery Devices Market Outlook to 2020 8BRIC Bariatric Surgery Devices Market Outlook to 2020 9BRIC Bariatric Surgery Devices Market Outlook to 2020 10
(Date:9/2/2014)... San Diego, CA (PRWEB) September 02, 2014 ... guide titled, “Is Group Therapy Right for Me?” The ... joining group therapy or counseling, in addition to common ... in group therapy improve not only from the interventions ... the group and receiving feedback from group members,” says ...
(Date:9/2/2014)... Friendship Village of Schaumburg is proud to introduce ... marketing presence and visually solidifies the relationship between ... Options,” said Stephen A. Yenchek, president and CEO ... we are making sure that our identity is ... , Friendship Village is a retirement community offering ...
(Date:9/2/2014)... Sept. 2, 2014 (HealthDay News) -- Complications are ... and reconstruction, a new study indicates. However, ... was associated with a slightly higher risk for ... study included more than 18,000 breast cancer patients ... double mastectomy with breast reconstruction and were followed ...
(Date:9/2/2014)... the emergency department within a few days of discharge do ... have lost trust in other parts of the health care ... today in Annals of Emergency Medicine ( "Return ... , "When asked why they did not follow up ... too severe to wait until their scheduled appointment or being ...
(Date:9/2/2014)... 2014 (HealthDay News) -- Two new studies further confirm ... 6-year-olds who were breast-fed have a lower risk of ... while the other finds a similar trend when it ... benefits of breast-feeding in the immediate newborn period," said ... in New York City. She was not involved in ...
Breaking Medicine News(10 mins):Health News:Friendship Village of Schaumburg In Illinois Announces New Logo 2Health News:Complication Rates Low With Mastectomy, Breast Reconstruction: Study 2Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:More Evidence Breast-Feeding Lowers Child's Risk of Infections, Allergies 2
... first time, scientists report a link between eating nuts and ... metabolic syndrome (MetS), who are at high risk for heart ... and decreases feelings of hunger, makes people feel happier and ... nuts (raw unpeeled walnuts, almonds and hazelnuts) a day to ...
... University Medical Center and Nationwide Children,s Hospital have developed a ... of people born with an inherited, progressive form of blindness ... of a clinical trial investigating the use of gene therapy ... people worldwide. The trial is being conducted by researchers at ...
... (BMI)are important risk factors for gestational diabetes mellitus (GDM) particularly ... published today (02 November) in BJOG: An International Journal ... the link between maternal age, BMI and racial origin with ... other. Data were collected on 585,291 pregnancies in ...
... of Michigan Health System laboratory study reveals a key trigger ... a new treatment for those with sickle cell disease. ... early edition of the Proceedings of the National Academy ... episodes and organ damage that are common complications of sickle ...
... depends on diagnostic tests, diagnostic physicians have a responsibility ... or unexpected findings. According to an article selected as ... recent edition of the Journal of the American ... growth of diagnostic testing appears to be placing physicians ...
... News) -- A new surgical method that uses a natural ... less scarring and faster recovery for patients, according to the ... used in this type of procedure is located behind the ... surgeries to remove skull base tumors require incisions through the ...
Cached Medicine News:Health News:Benefits of nut consumption for people with abdominal obesity, high blood sugar, high blood pressure 2Health News:Ohio State researchers design a viral vector to treat a genetic form of blindness 2Health News:Age and BMI can predict likelihood of developing gestational diabetes new research suggests 2Health News:Age and BMI can predict likelihood of developing gestational diabetes new research suggests 3Health News:Researchers reveal potential treatment for sickle cell disease 2Health News:Diagnostic physicians at increased risk for medical malpractice claims due to communication failures 2Health News:New Technique to Remove Skull Tumors May Mean Less Scarring 2
... Designed for the Anterior Segment The ... lens practitioners and ophthalmologists specializing in the anterior ... emergency rooms. Video- c-mount camera on the BD ... port. Standard magnification in 10 and 16 X ...
... FVL is a new functional test which ... Activated Protein C Resistance caused by the ... to other commercially available methods, Pefakit APC-R ... or S, Lupus Anticoagulants, Elevated FVIII levels, ...
... Used for venous pressure monitoring, blood ... fluids. Turbo-Flo polyurethane PICC line sets ... Rates, Micropuncture Introducer Needle, ... be trimmed to patient specific anatomy. ...
Assess serum Gc-globulin levels in patients with multiple trauma, fulminant liver failure, acetaminophen overdose, and sepsis....
Medicine Products: